Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease : a community-based retrospective longitudinal cohort study

Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predict...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of gastroenterology Ročník 48; číslo 3; s. 413 - 422
Hlavní autoři: Miyake, Teruki, Kumagi, Teru, Hirooka, Masashi, Furukawa, Shinya, Koizumi, Mitsuhito, Tokumoto, Yoshio, Ueda, Teruhisa, Yamamoto, Shin, Abe, Masanori, Kitai, Kohichiro, Hiasa, Yoichi, Matsuura, Bunzo, Onji, Morikazu
Médium: Journal Article
Jazyk:angličtina
Vydáno: Japan Springer Japan 01.03.2013
Springer
Springer Nature B.V
Témata:
ISSN:0944-1174, 1435-5922, 1435-5922
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. Methods In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan–Meier method. Results Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m 2 for men and 22.2 kg/m 2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes ( P  < 0.001). Conclusion BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
AbstractList Background: Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. Methods: In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method. Results: Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m super(2) for men and 22.2 kg/m super(2) for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001). Conclusion: BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplanâ[euro]"Meier method. Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23Â kg/m^sup 2^ for men and 22.2Â kg/m^sup 2^ for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (PÂ <Â 0.001). BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.[PUBLICATION ABSTRACT]
Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset.BACKGROUNDNonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset.In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method.METHODSIn a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method.Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m2 for men and 22.2 kg/m2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001).RESULTSMultivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m2 for men and 22.2 kg/m2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001).BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.CONCLUSIONBMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method. Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m.sup.2 for men and 22.2 kg/m.sup.2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001). BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. Methods In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan–Meier method. Results Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m 2 for men and 22.2 kg/m 2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes ( P  < 0.001). Conclusion BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. Methods In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method. Results Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m.sup.2 for men and 22.2 kg/m.sup.2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001). Conclusion BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able to easily identify high-risk NAFLD patients so that intervention can begin at an earlier stage. We sought to identify the predictive factors for NAFLD onset. In a community-based, longitudinal design, the records of 6,403 Japanese subjects were reviewed to identify those meeting the criteria for NAFLD onset. Univariate and multivariate logistic regression analyses were used to identify predictive factors for NAFLD onset. The accuracy of different models was evaluated according to their areas under the receiver operating characteristic curves. Comparative risk analysis was performed using the Kaplan-Meier method. Multivariate analysis of 400 subjects who met the criteria for the onset of NAFLD during the observation period confirmed that body mass index (BMI) at baseline was the most useful predictive factor for NAFLD onset in both sexes. Cutoff levels of BMI for NAFLD onset were estimated at 23 kg/m2 for men and 22.2 kg/m2 for women. The cumulative onset rate of NAFLD was significantly higher in the high BMI group than in the low BMI group in both sexes (P < 0.001). BMI was confirmed as the most useful predictive factor for NAFLD onset in both sexes; its cutoff levels were similar to those recommended by the World Health Organization for helping to prevent metabolic disease. An accurate BMI cutoff level will enable clinicians to identify subjects at risk for NAFLD onset.
Audience Academic
Author HIASA Yoichi
UEDA Teruhisa
TOKUMOTO Yoshio
MIYAKE Teruki
KUMAGI Teru
FURUKAWA Shinya
YAMAMOTO Shin
KITAI Kohichiro
ONJI Morikazu
HIROOKA Masashi
KOIZUMI Mitsuhito
MATSUURA Bunzo
ABE Masanori
Author_xml – sequence: 1
  givenname: Teruki
  surname: Miyake
  fullname: Miyake, Teruki
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 2
  givenname: Teru
  surname: Kumagi
  fullname: Kumagi, Teru
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 3
  givenname: Masashi
  surname: Hirooka
  fullname: Hirooka, Masashi
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 4
  givenname: Shinya
  surname: Furukawa
  fullname: Furukawa, Shinya
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 5
  givenname: Mitsuhito
  surname: Koizumi
  fullname: Koizumi, Mitsuhito
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime General Health Care Association
– sequence: 6
  givenname: Yoshio
  surname: Tokumoto
  fullname: Tokumoto, Yoshio
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 7
  givenname: Teruhisa
  surname: Ueda
  fullname: Ueda, Teruhisa
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 8
  givenname: Shin
  surname: Yamamoto
  fullname: Yamamoto, Shin
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 9
  givenname: Masanori
  surname: Abe
  fullname: Abe, Masanori
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 10
  givenname: Kohichiro
  surname: Kitai
  fullname: Kitai, Kohichiro
  organization: Ehime General Health Care Association
– sequence: 11
  givenname: Yoichi
  surname: Hiasa
  fullname: Hiasa, Yoichi
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 12
  givenname: Bunzo
  surname: Matsuura
  fullname: Matsuura, Bunzo
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
– sequence: 13
  givenname: Morikazu
  surname: Onji
  fullname: Onji, Morikazu
  email: onjimori@m.ehime-u.ac.jp
  organization: Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
BackLink https://cir.nii.ac.jp/crid/1573668925947320576$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/22933183$$D View this record in MEDLINE/PubMed
BookMark eNqFkslu1jAUhSNURAd4ADbIEizYpHiMbXalYpIqsYG15dg3rask_rGdiv91eFIcpRVQoSJPytV3ju34HDcHc5yhaZ4TfEowlm8yxoKJFhPa4k7gVj1qjgivFaEpPWiOsOa8JUTyw-Y452uMCcNCPWkOKdWMEcWOmp_vot-jyeaMwuzhBwoZlStAU8wFLRmGZUS7BD64Em4ADdaVmNBQx0rFOUNBcUD1YHZ08SqOwVWolD0aK5-QDxlsBvQWWeTiNC1zKPu2ryWPEpQU8w426zHOl6EsPlQntFqlgnL93j9tHg92zPDsdj1pvn14__X8U3vx5ePn87OL1olOlpZb12PaU7CU9Z4qGDgXjnZu6KyXILXD2iuK7Tr3msle9RwIMEk1td6xk-b15rtL8fsCuZgpZAfjaGeISzZEackUX_t_UUa57jBlpKIv76HXcUn1jhtFpVRC_6Yu7QgmzEMsybrV1JxJwoUSUq_bnv6Dqs3DFFzNxhBq_S_Bi9vNl34Cb3YpTDbtzd37V0BugKsvkRMMxoViS4hzdQ6jIdisSTNb0kxNmlmTZlRVknvKO_OHNHTT5MrOl5D--BcPiF5tojmEerp1JkKyrlOaCs0lo1jIjv0CQEjwDA
CitedBy_id crossref_primary_10_1183_23120541_00325_2022
crossref_primary_10_36290_vnl_2019_099
crossref_primary_10_1089_ars_2013_5655
crossref_primary_10_1016_j_tem_2021_05_002
crossref_primary_10_1038_s43856_022_00196_3
crossref_primary_10_4103_jfmpc_jfmpc_1609_24
crossref_primary_10_1371_journal_pone_0192396
crossref_primary_10_1016_j_atherosclerosis_2023_05_015
crossref_primary_10_1016_j_clnu_2016_12_006
crossref_primary_10_1097_MD_0000000000043108
crossref_primary_10_1007_s00535_014_0989_0
crossref_primary_10_1016_j_biopha_2016_04_013
crossref_primary_10_1016_j_cca_2017_01_021
crossref_primary_10_1038_s41598_018_36460_7
crossref_primary_10_1055_a_1880_2283
crossref_primary_10_1111_hepr_13646
crossref_primary_10_1016_j_physbeh_2017_01_019
crossref_primary_10_3389_fmed_2022_995749
crossref_primary_10_1016_j_imu_2024_101513
crossref_primary_10_3389_fendo_2023_1094101
crossref_primary_10_1111_jgh_12238
crossref_primary_10_1111_jgh_13760
crossref_primary_10_1007_s13340_014_0175_x
crossref_primary_10_1111_liv_13709
crossref_primary_10_1007_s00535_014_0959_6
crossref_primary_10_1016_j_aohep_2020_100301
crossref_primary_10_1016_j_asjsur_2022_05_001
crossref_primary_10_1038_s41598_021_88409_y
crossref_primary_10_1016_j_ypmed_2024_107971
crossref_primary_10_1186_s12889_020_08475_1
crossref_primary_10_1007_s00535_015_1058_z
crossref_primary_10_1016_j_numecd_2023_09_009
crossref_primary_10_1007_s00535_012_0735_4
crossref_primary_10_1038_s41598_018_33419_6
crossref_primary_10_1097_MD_0000000000039437
crossref_primary_10_1016_j_blre_2021_100908
crossref_primary_10_4093_dmj_2023_0200
crossref_primary_10_1038_srep23279
crossref_primary_10_1080_03670244_2021_1875453
crossref_primary_10_1097_MD_0000000000025738
crossref_primary_10_1016_j_physbeh_2018_02_044
crossref_primary_10_1097_MD_0000000000031437
crossref_primary_10_3350_cmh_2020_0261
crossref_primary_10_1097_TP_0000000000005401
crossref_primary_10_1371_journal_pone_0107882
crossref_primary_10_1111_obr_12407
crossref_primary_10_1055_a_1880_2388
crossref_primary_10_25122_jml_2018_0031
crossref_primary_10_1016_j_asjsur_2021_07_046
crossref_primary_10_1016_j_leukres_2024_107609
crossref_primary_10_1159_000357776
crossref_primary_10_1186_s12944_022_01717_8
crossref_primary_10_1371_journal_pone_0177249
crossref_primary_10_3892_br_2014_309
crossref_primary_10_1097_MD_0000000000026415
crossref_primary_10_1371_journal_pone_0223683
crossref_primary_10_1002_biof_2133
crossref_primary_10_3389_fpubh_2024_1437432
crossref_primary_10_1111_jgh_12251
crossref_primary_10_1016_j_hbpd_2021_08_004
crossref_primary_10_1007_s11695_016_2054_y
Cites_doi 10.1016/j.diabres.2005.01.009
10.1038/sj.ijo.0802486
10.1007/s00535-012-0534-y
10.2337/dc10-1991
10.1136/bmj.38050.593634.63
10.1023/A:1005661516165
10.2337/diacare.26.12.3351-a
10.1038/ncpgasthep0879
10.1111/j.1440-1746.2004.03312.x
10.1136/gut.2003.027086
10.1016/j.jhep.2011.05.027
10.2169/internalmedicine.43.289
10.3164/jcbn.08-269
10.1373/clinchem.2006.081257
10.1002/hep.20466
10.1016/j.jhep.2005.02.042
10.1016/S0168-8278(02)00099-5
10.1053/jhep.2003.50161
10.1002/hep.23505
10.1016/S0140-6736(03)15268-3
10.1371/journal.pone.0011578
10.1056/NEJMra011775
10.1007/s00535-003-1178-8
10.1046/j.1467-789X.2002.00065.x
10.7326/0003-4819-143-10-200511150-00009
10.3748/wjg.v13.i10.1579
10.7326/0003-4819-132-2-200001180-00004
10.7326/0003-4819-137-1-200207020-00006
10.1253/circj.66.987
ContentType Journal Article
Copyright Springer 2012
COPYRIGHT 2013 Springer
Springer Japan 2013
Copyright_xml – notice: Springer 2012
– notice: COPYRIGHT 2013 Springer
– notice: Springer Japan 2013
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7T5
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
H94
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
7TS
DOI 10.1007/s00535-012-0650-8
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Immunology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database (subscription)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Physical Education Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Physical Education Index
DatabaseTitleList Physical Education Index
ProQuest One Academic Middle East (New)
MEDLINE - Academic



MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1435-5922
EndPage 422
ExternalDocumentID 2937619311
A714585794
22933183
10_1007_s00535_012_0650_8
10031169216
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
.86
.VR
06C
06D
0R~
0VY
199
1N0
203
29K
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
36B
4.4
406
408
409
40D
40E
5GY
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAWTL
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSTC
ACZOJ
ADBBV
ADHIR
ADHKG
ADIMF
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHBYD
AHIZS
AHKAY
AHMBA
AHPBZ
AHSBF
AHWEU
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATHPR
AXYYD
AYFIA
AZFZN
AZQEC
B-.
BA0
BDATZ
BENPR
BGNMA
BKEYQ
BKNYI
BPHCQ
BSONS
BVXVI
CCPQU
CS3
CSCUP
D-I
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
IHR
IJ-
IKXTQ
IMOTQ
INH
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KPH
LAS
LLZTM
M0R
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P2P
P9S
PCD
PF0
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
ROL
RPX
RRX
RSV
RYH
S16
S27
S37
S3B
SAP
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YLTOR
Z45
ZMTXR
ZOVNA
~EX
~KM
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.GJ
2.D
28-
2P1
2VQ
3O-
3V.
53G
5QI
ACUDM
ADINQ
AEFIE
AFEXP
AGGDS
AHAVH
BBWZM
CAG
COF
EN4
GQ6
GRRUI
IHE
KOW
NDZJH
RIG
RNI
RZK
S1Z
S26
S28
SCLPG
T16
Z7U
Z7W
Z82
Z83
Z87
Z8O
Z8Q
Z8V
Z8W
Z91
AAYXX
ABRTQ
AFFHD
AFOHR
CITATION
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7XB
8FK
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
7TS
ID FETCH-LOGICAL-c567t-4acb02b2ea23bd28ef445c26cf6ad7e79c09d820a9d82b937b8b4e1e37292adc3
IEDL.DBID RSV
ISICitedReferencesCount 73
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000317305000015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0944-1174
1435-5922
IngestDate Sun Nov 09 14:43:50 EST 2025
Sun Nov 09 13:19:26 EST 2025
Tue Nov 04 19:50:22 EST 2025
Sat Nov 29 13:42:32 EST 2025
Sat Nov 29 09:50:10 EST 2025
Mon Jul 21 06:05:24 EDT 2025
Sat Nov 29 06:46:58 EST 2025
Tue Nov 18 22:00:34 EST 2025
Fri Feb 21 02:29:36 EST 2025
Thu Jun 26 22:00:51 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Body mass index
Nonalcoholic fatty liver disease
Predictive factor
Metabolic disorders
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-4acb02b2ea23bd28ef445c26cf6ad7e79c09d820a9d82b937b8b4e1e37292adc3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-2292-7750
0000-0002-9905-5356
0000-0002-0041-7688
PMID 22933183
PQID 1324277859
PQPubID 33411
PageCount 10
ParticipantIDs proquest_miscellaneous_1897384384
proquest_miscellaneous_1324960231
proquest_journals_1324277859
gale_infotracmisc_A714585794
gale_infotracacademiconefile_A714585794
pubmed_primary_22933183
crossref_citationtrail_10_1007_s00535_012_0650_8
crossref_primary_10_1007_s00535_012_0650_8
springer_journals_10_1007_s00535_012_0650_8
nii_cinii_1573668925947320576
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
– name: Tokyo
PublicationTitle Journal of gastroenterology
PublicationTitleAbbrev J Gastroenterol
PublicationTitleAlternate J Gastroenterol
PublicationYear 2013
Publisher Springer Japan
Springer
Springer Nature B.V
Publisher_xml – name: Springer Japan
– name: Springer
– name: Springer Nature B.V
References Nugent, Younossi (CR24) 2007; 4
Marchesini, Bugianesi, Forlani, Cerrelli, Lenzi, Manini (CR5) 2003; 37
Miyake, Kumagi, Hirooka, Koizumi, Furukawa, Ueda (CR14) 2012; 47
Shiwaku, Anuurad, Enkhmaa, Nogi, Kitajima, Shimono (CR27) 2004; 28
Kojima, Watanabe, Numata, Ogawa, Matsuzaki (CR20) 2003; 38
Deurenberg, Deurenberg-Yap, Guricci (CR29) 2002; 3
Misra, Misra, Wijesuriya, Banerjee (CR28) 2007; 125
Xu, Yu, Xu, Miao, Li (CR16) 2010; 5
Gupte, Amarapurkar, Agal, Baijal, Kulshrestha, Pramanik (CR9) 2004; 19
Fan, Zhu, Li, Chen, Li, Dai (CR3) 2005; 43
Kim, Nam, Jee, Han, Oh, Suh (CR23) 2004; 328
Misra, Wasir, Vikram (CR30) 2005; 68
Yu, Xu, Xu, Yu, Miao, Li (CR15) 2011; 56
Angulo (CR4) 2002; 18
Browning, Szczepaniak, Dobbins, Nuremberg, Horton, Cohen (CR2) 2004; 40
Omagari, Morikawa, Nagaoka, Sadakane, Sato, Hamasaki (CR18) 2009; 45
Chang, Ryu, Sung, Jang (CR17) 2007; 53
Hamaguchi, Kojima, Takeda, Nakagawa, Taniguchi, Fujii (CR7) 2005; 143
Hamaguchi, Kojima, Takeda, Nagata, Takeda, Sarui (CR12) 2007; 13
Shimada, Hashimoto, Taniai, Hasegawa, Okuda, Hayashi (CR6) 2002; 37
(CR19) 2002; 66
Lee, Shim, Lee, Lee, Kim, Lim (CR22) 2010; 51
Fujikawa, Ohata, Honda, Miyazoe, Ichikawa, Ishikawa (CR25) 2004; 43
Assy, Kaita, Mymin, Levy, Rosser, Minuk (CR10) 2000; 45
Prati, Taioli, Zanella, Torre, Butelli, Del Vecchio (CR21) 2002; 137
Bae, Rhee, Lee, Park, Park, Oh (CR13) 2011; 34
Bellentani, Saccoccio, Masutti, Crocè, Brandi, Sasso (CR1) 2000; 132
Akbar, Kawther (CR8) 2003; 26
Donati, Stagni, Piscaglia, Venturoli, Morselli-Labate, Rasciti (CR11) 2004; 53
(CR26) 2004; 363
M Hamaguchi (650_CR7) 2005; 143
JK Lee (650_CR22) 2010; 51
A Misra (650_CR28) 2007; 125
P Angulo (650_CR4) 2002; 18
C Nugent (650_CR24) 2007; 4
G Donati (650_CR11) 2004; 53
N Assy (650_CR10) 2000; 45
M Shimada (650_CR6) 2002; 37
C Yu (650_CR15) 2011; 56
K Fujikawa (650_CR25) 2004; 43
T Miyake (650_CR14) 2012; 47
M Hamaguchi (650_CR12) 2007; 13
P Deurenberg (650_CR29) 2002; 3
DH Akbar (650_CR8) 2003; 26
S Bellentani (650_CR1) 2000; 132
JG Fan (650_CR3) 2005; 43
JC Bae (650_CR13) 2011; 34
Y Chang (650_CR17) 2007; 53
K Omagari (650_CR18) 2009; 45
A Misra (650_CR30) 2005; 68
HC Kim (650_CR23) 2004; 328
G Marchesini (650_CR5) 2003; 37
650_CR19
P Gupte (650_CR9) 2004; 19
C Xu (650_CR16) 2010; 5
S Kojima (650_CR20) 2003; 38
WHO Expert Consultation (650_CR26) 2004; 363
JD Browning (650_CR2) 2004; 40
D Prati (650_CR21) 2002; 137
K Shiwaku (650_CR27) 2004; 28
12093239 - Ann Intern Med. 2002 Jul 2;137(1):1-10
23325165 - J Gastroenterol. 2013 Apr;48(4):549
16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8
21278140 - Diabetes Care. 2011 Mar;34(3):727-9
22331365 - J Gastroenterol. 2012 Jun;47(6):696-703
15565570 - Hepatology. 2004 Dec;40(6):1387-95
17461452 - World J Gastroenterol. 2007 Mar 14;13(10 ):1579-84
17496360 - Indian J Med Res. 2007 Mar;125(3):345-54
12164465 - Obes Rev. 2002 Aug;3(3):141-6
10644271 - Ann Intern Med. 2000 Jan 18;132(2):112-7
12419927 - Circ J. 2002 Nov;66(11):987-92
21756851 - J Hepatol. 2012 Jan;56(1):241-7
19590708 - J Clin Biochem Nutr. 2009 Jul;45(1):56-67
17667992 - Nat Clin Pract Gastroenterol Hepatol. 2007 Aug;4(8):432-41
15242486 - J Gastroenterol Hepatol. 2004 Aug;19(8):854-8
12076877 - J Hepatol. 2002 Jul;37(1):154-60
20644649 - PLoS One. 2010 Jul 14;5(7):e11578
17272484 - Clin Chem. 2007 Apr;53(4):686-92
23361473 - J Gastroenterol. 2013 Apr;48(4):550-1
15860248 - Diabetes Res Clin Pract. 2005 May;68(2):178-9
11961152 - N Engl J Med. 2002 Apr 18;346(16):1221-31
14726171 - Lancet. 2004 Jan 10;363(9403):157-63
15194655 - Gut. 2004 Jul;53(7):1020-3
14557832 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):152-8
11117562 - Dig Dis Sci. 2000 Oct;45(10):1929-34
12668987 - Hepatology. 2003 Apr;37(4):917-23
14614602 - J Gastroenterol. 2003;38(10):954-61
20162730 - Hepatology. 2010 May;51(5):1577-83
15028636 - BMJ. 2004 Apr 24;328(7446):983
15168770 - Intern Med. 2004 Apr;43(4):289-94
14633828 - Diabetes Care. 2003 Dec;26(12):3351-2
16006003 - J Hepatol. 2005 Sep;43(3):508-14
References_xml – volume: 66
  start-page: 987
  year: 2002
  end-page: 92
  ident: CR19
  article-title: New criteria for ‘obesity disease’ in Japan
  publication-title: Circ J
– volume: 125
  start-page: 345
  year: 2007
  end-page: 354
  ident: CR28
  article-title: The metabolic syndrome in South Asians: continuing escalation & possible solutions
  publication-title: Indian J Med Res
– volume: 68
  start-page: 178
  year: 2005
  end-page: 179
  ident: CR30
  article-title: Action and research are needed for evaluation of optimal definitions of anthropometric parameters and metabolic syndrome for Asians
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2005.01.009
– volume: 28
  start-page: 152
  year: 2004
  end-page: 158
  ident: CR27
  article-title: Overweight Japanese with body mass indexes of 23.0–24.9 have higher risks for obesity-associated disorders: a comparison of Japanese and Mongolians
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0802486
– volume: 47
  start-page: 696
  year: 2012
  end-page: 703
  ident: CR14
  article-title: Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-012-0534-y
– volume: 34
  start-page: 727
  year: 2011
  end-page: 729
  ident: CR13
  article-title: Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study
  publication-title: Diabetes Care
  doi: 10.2337/dc10-1991
– volume: 328
  start-page: 983
  year: 2004
  ident: CR23
  article-title: Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.38050.593634.63
– volume: 45
  start-page: 1929
  year: 2000
  end-page: 1934
  ident: CR10
  article-title: Fatty infiltration of liver in hyperlipidemic patients
  publication-title: Dig Dis Sci
  doi: 10.1023/A:1005661516165
– volume: 26
  start-page: 3351
  year: 2003
  end-page: 3352
  ident: CR8
  article-title: Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.12.3351-a
– volume: 4
  start-page: 432
  year: 2007
  end-page: 441
  ident: CR24
  article-title: Evaluation and management of obesity-related nonalcoholic fatty liver disease
  publication-title: Nat Clin Pract Gastroenterol Hepatol
  doi: 10.1038/ncpgasthep0879
– volume: 19
  start-page: 854
  year: 2004
  end-page: 858
  ident: CR9
  article-title: Non-alcoholic steatohepatitis in type 2 diabetes mellitus
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2004.03312.x
– volume: 53
  start-page: 1020
  year: 2004
  end-page: 1023
  ident: CR11
  article-title: Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
  publication-title: Gut
  doi: 10.1136/gut.2003.027086
– volume: 56
  start-page: 241
  year: 2011
  end-page: 247
  ident: CR15
  article-title: Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.05.027
– volume: 43
  start-page: 289
  year: 2004
  end-page: 294
  ident: CR25
  article-title: Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.43.289
– volume: 45
  start-page: 56
  year: 2009
  end-page: 67
  ident: CR18
  article-title: Predictive factors for the development or regression of fatty liver in Japanese adults
  publication-title: J Clin Biochem Nutr
  doi: 10.3164/jcbn.08-269
– volume: 143
  start-page: 722
  year: 2005
  end-page: 728
  ident: CR7
  article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
  publication-title: Ann Intern Med
– volume: 137
  start-page: 1
  year: 2002
  end-page: 9
  ident: CR21
  article-title: Updated definitions of healthy ranges for serum alanine aminotransferase levels
  publication-title: Ann Intern Med
– volume: 53
  start-page: 686
  year: 2007
  end-page: 692
  ident: CR17
  article-title: Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2006.081257
– volume: 13
  start-page: 1579
  year: 2007
  end-page: 1584
  ident: CR12
  article-title: Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
  publication-title: World J Gastroenterol
– volume: 40
  start-page: 1387
  year: 2004
  end-page: 1395
  ident: CR2
  article-title: Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity
  publication-title: Hepatology
  doi: 10.1002/hep.20466
– volume: 43
  start-page: 508
  year: 2005
  end-page: 514
  ident: CR3
  article-title: Prevalence of and risk factors for fatty liver in a general population of Shanghai, China
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.02.042
– volume: 37
  start-page: 154
  year: 2002
  end-page: 160
  ident: CR6
  article-title: Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00099-5
– volume: 37
  start-page: 917
  year: 2003
  end-page: 923
  ident: CR5
  article-title: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50161
– volume: 51
  start-page: 1577
  year: 2010
  end-page: 1583
  ident: CR22
  article-title: Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology
  publication-title: Hepatology
  doi: 10.1002/hep.23505
– volume: 363
  start-page: 157
  year: 2004
  end-page: 163
  ident: CR26
  article-title: Appropriate body-mass index for Asian populations and its implications for policy and investigation strategies
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)15268-3
– volume: 5
  start-page: e11578
  year: 2010
  ident: CR16
  article-title: High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0011578
– volume: 18
  start-page: 1221
  year: 2002
  end-page: 1231
  ident: CR4
  article-title: Nonalcoholic fatty liver disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra011775
– volume: 38
  start-page: 954
  year: 2003
  end-page: 961
  ident: CR20
  article-title: Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-003-1178-8
– volume: 3
  start-page: 141
  year: 2002
  end-page: 146
  ident: CR29
  article-title: Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship
  publication-title: Obes Rev
  doi: 10.1046/j.1467-789X.2002.00065.x
– volume: 132
  start-page: 112
  year: 2000
  end-page: 117
  ident: CR1
  article-title: Prevalence of and risk factors for hepatic steatosis in Northern Italy
  publication-title: Ann Intern Med
– volume: 37
  start-page: 917
  year: 2003
  ident: 650_CR5
  publication-title: Hepatology
  doi: 10.1053/jhep.2003.50161
– volume: 143
  start-page: 722
  year: 2005
  ident: 650_CR7
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-10-200511150-00009
– volume: 43
  start-page: 289
  year: 2004
  ident: 650_CR25
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.43.289
– volume: 328
  start-page: 983
  year: 2004
  ident: 650_CR23
  publication-title: BMJ
  doi: 10.1136/bmj.38050.593634.63
– volume: 51
  start-page: 1577
  year: 2010
  ident: 650_CR22
  publication-title: Hepatology
  doi: 10.1002/hep.23505
– volume: 3
  start-page: 141
  year: 2002
  ident: 650_CR29
  publication-title: Obes Rev
  doi: 10.1046/j.1467-789X.2002.00065.x
– volume: 125
  start-page: 345
  year: 2007
  ident: 650_CR28
  publication-title: Indian J Med Res
– volume: 53
  start-page: 1020
  year: 2004
  ident: 650_CR11
  publication-title: Gut
  doi: 10.1136/gut.2003.027086
– volume: 13
  start-page: 1579
  year: 2007
  ident: 650_CR12
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i10.1579
– volume: 37
  start-page: 154
  year: 2002
  ident: 650_CR6
  publication-title: J Hepatol
  doi: 10.1016/S0168-8278(02)00099-5
– volume: 4
  start-page: 432
  year: 2007
  ident: 650_CR24
  publication-title: Nat Clin Pract Gastroenterol Hepatol
  doi: 10.1038/ncpgasthep0879
– volume: 132
  start-page: 112
  year: 2000
  ident: 650_CR1
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-132-2-200001180-00004
– volume: 38
  start-page: 954
  year: 2003
  ident: 650_CR20
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-003-1178-8
– volume: 45
  start-page: 56
  year: 2009
  ident: 650_CR18
  publication-title: J Clin Biochem Nutr
  doi: 10.3164/jcbn.08-269
– volume: 56
  start-page: 241
  year: 2011
  ident: 650_CR15
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2011.05.027
– volume: 28
  start-page: 152
  year: 2004
  ident: 650_CR27
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0802486
– volume: 137
  start-page: 1
  year: 2002
  ident: 650_CR21
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-137-1-200207020-00006
– volume: 40
  start-page: 1387
  year: 2004
  ident: 650_CR2
  publication-title: Hepatology
  doi: 10.1002/hep.20466
– volume: 68
  start-page: 178
  year: 2005
  ident: 650_CR30
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2005.01.009
– volume: 19
  start-page: 854
  year: 2004
  ident: 650_CR9
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/j.1440-1746.2004.03312.x
– volume: 34
  start-page: 727
  year: 2011
  ident: 650_CR13
  publication-title: Diabetes Care
  doi: 10.2337/dc10-1991
– volume: 26
  start-page: 3351
  year: 2003
  ident: 650_CR8
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.12.3351-a
– volume: 47
  start-page: 696
  year: 2012
  ident: 650_CR14
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-012-0534-y
– volume: 53
  start-page: 686
  year: 2007
  ident: 650_CR17
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2006.081257
– volume: 18
  start-page: 1221
  year: 2002
  ident: 650_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra011775
– volume: 5
  start-page: e11578
  year: 2010
  ident: 650_CR16
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0011578
– volume: 363
  start-page: 157
  year: 2004
  ident: 650_CR26
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)15268-3
– volume: 43
  start-page: 508
  year: 2005
  ident: 650_CR3
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2005.02.042
– volume: 45
  start-page: 1929
  year: 2000
  ident: 650_CR10
  publication-title: Dig Dis Sci
  doi: 10.1023/A:1005661516165
– ident: 650_CR19
  doi: 10.1253/circj.66.987
– reference: 20644649 - PLoS One. 2010 Jul 14;5(7):e11578
– reference: 15028636 - BMJ. 2004 Apr 24;328(7446):983
– reference: 12668987 - Hepatology. 2003 Apr;37(4):917-23
– reference: 16006003 - J Hepatol. 2005 Sep;43(3):508-14
– reference: 12093239 - Ann Intern Med. 2002 Jul 2;137(1):1-10
– reference: 10644271 - Ann Intern Med. 2000 Jan 18;132(2):112-7
– reference: 14557832 - Int J Obes Relat Metab Disord. 2004 Jan;28(1):152-8
– reference: 21278140 - Diabetes Care. 2011 Mar;34(3):727-9
– reference: 17496360 - Indian J Med Res. 2007 Mar;125(3):345-54
– reference: 17461452 - World J Gastroenterol. 2007 Mar 14;13(10 ):1579-84
– reference: 20162730 - Hepatology. 2010 May;51(5):1577-83
– reference: 14726171 - Lancet. 2004 Jan 10;363(9403):157-63
– reference: 21756851 - J Hepatol. 2012 Jan;56(1):241-7
– reference: 11961152 - N Engl J Med. 2002 Apr 18;346(16):1221-31
– reference: 17667992 - Nat Clin Pract Gastroenterol Hepatol. 2007 Aug;4(8):432-41
– reference: 15194655 - Gut. 2004 Jul;53(7):1020-3
– reference: 12164465 - Obes Rev. 2002 Aug;3(3):141-6
– reference: 15242486 - J Gastroenterol Hepatol. 2004 Aug;19(8):854-8
– reference: 23361473 - J Gastroenterol. 2013 Apr;48(4):550-1
– reference: 12419927 - Circ J. 2002 Nov;66(11):987-92
– reference: 16287793 - Ann Intern Med. 2005 Nov 15;143(10 ):722-8
– reference: 17272484 - Clin Chem. 2007 Apr;53(4):686-92
– reference: 23325165 - J Gastroenterol. 2013 Apr;48(4):549
– reference: 11117562 - Dig Dis Sci. 2000 Oct;45(10):1929-34
– reference: 14614602 - J Gastroenterol. 2003;38(10):954-61
– reference: 15168770 - Intern Med. 2004 Apr;43(4):289-94
– reference: 19590708 - J Clin Biochem Nutr. 2009 Jul;45(1):56-67
– reference: 22331365 - J Gastroenterol. 2012 Jun;47(6):696-703
– reference: 12076877 - J Hepatol. 2002 Jul;37(1):154-60
– reference: 14633828 - Diabetes Care. 2003 Dec;26(12):3351-2
– reference: 15860248 - Diabetes Res Clin Pract. 2005 May;68(2):178-9
– reference: 15565570 - Hepatology. 2004 Dec;40(6):1387-95
SSID ssj0013058
Score 2.3253574
Snippet Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians...
Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians must be able...
Background Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians...
Background: Nonalcoholic fatty liver disease (NAFLD) can progress to advanced liver disease and non-liver-related diseases. To prevent NAFLD onset, clinicians...
SourceID proquest
gale
pubmed
crossref
springer
nii
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 413
SubjectTerms Abdominal Surgery
Adolescent
Adult
Aged
Aged, 80 and over
Analysis
Biliary Tract
Biomarkers - blood
Body Mass Index
Colorectal Surgery
Development and progression
Early Diagnosis
Fatty liver
Fatty Liver - diagnosis
Fatty Liver - epidemiology
Fatty Liver - etiology
Fatty Liver - physiopathology
Female
Gastroenterology
Hepatology
Humans
Japan - epidemiology
Longitudinal Studies
Male
Medicine
Medicine & Public Health
Metabolic disorders
Middle Aged
Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease
Original Article—Liver
Pancreas
Predictive factor
Prevention
Retrospective Studies
Risk Factors
Sex Factors
Surgical Oncology
Young Adult
SummonAdditionalLinks – databaseName: Nursing & Allied Health Database
  dbid: 7RV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA_eKeKL33rVOxlBEJRwbfqRxhc5xcMXDxGVeytpksLC3nZtuwf75_ifOpOmey7qvgilL52GtJnO_KYzmR9jL1zRKOWs5Tnl_7NGK45hRM5TI61oFDo9bTzZhDw7K8_P1efww60PZZWTTfSG2raG_pEfJ-T5pSxz9Xb5gxNrFGVXA4XGHrueEDZGfZZfvl9lEWLPz4kRTMYThN5TVjP2TUTzlMrWBCeQwsstvxSs895iNvsb8vwja-qd0emd_32Mu-x2gKFwMurNPXbNLe6zm59Cov0B-_mutWu4QGQNvp8izHpAqAgXbT_AqnfNag7LjsTJXMLI2gMIgL0UVWgP0DawIJzvOXhnBoWGYQ1zKgSBkBd6AxrMuEVlWHPyqBY6N3TttAEU5i0RKq0skXcBjdQN4FviPmTfTj98ff-RBzYHbvJCDjzTpo5FLZwWaW1F6Zosy40oTFNoK51UJlYW8Yimc42oqS7rzCWO8opCW5M-Yvs4a3fAgHb3yhxD6EKjzdGlcq7OjcVIVsaqMSJi8bSWlQmtzolxY15tmjT75a9w-Sta_qqM2KvNLcuxz8cu4ZekIBXZABzX6LCVAWdH3bSqE5lkGIahqYvY4ZYkfrtm6_IRqhjOkc5JLtOiKBUGpJlMBQLpAm-ftKgKtqWvrlQoYs83l2lkqpdbuHY1ymBsiuB9h0ypZFpmeETs8ajYm0cXiALJ2kfs9aTpv03gX-_lye7pPmW3hCcToQq-Q7Y_dCt3xG6Yy2HWd8_8p_sLoZZHQA
  priority: 102
  providerName: ProQuest
Title Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease : a community-based retrospective longitudinal cohort study
URI https://cir.nii.ac.jp/crid/1573668925947320576
https://link.springer.com/article/10.1007/s00535-012-0650-8
https://www.ncbi.nlm.nih.gov/pubmed/22933183
https://www.proquest.com/docview/1324277859
https://www.proquest.com/docview/1324960231
https://www.proquest.com/docview/1897384384
Volume 48
WOSCitedRecordID wos000317305000015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Consumer Health Database (subscription)
  customDbUrl:
  eissn: 1435-5922
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0013058
  issn: 0944-1174
  databaseCode: M0R
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/familyhealth
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1435-5922
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0013058
  issn: 0944-1174
  databaseCode: 7X7
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1435-5922
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0013058
  issn: 0944-1174
  databaseCode: 7RV
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1435-5922
  dateEnd: 20171231
  omitProxy: false
  ssIdentifier: ssj0013058
  issn: 0944-1174
  databaseCode: BENPR
  dateStart: 19970301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLINK Contemporary 1997-Present
  customDbUrl:
  eissn: 1435-5922
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013058
  issn: 0944-1174
  databaseCode: RSV
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9swEBdLO8a-7P3w1pYbDAYbBkd-SNq3drTsS0PJtpJvRpZkMKRxsZ1B_pz9p7uT7WxhXWGDcBB8FhfldPod92LsrctKpZy1YUrx_6TUKkQ3Ig1jIywvFV562vhhE2I2k4uFuhjquNsx230MSXpLvS12861I0PXlIcGKUE7YPt52kuY1zL9c_godRH4oJ7otSThFvD2GMm9aYucyGkzyZFVVN8HNP0Kl_gY6e_hfsj9iDwbACce9hjxmd9zqCbt3PoTUn7IfJ7XdwBViaPCdE6FqAUEhXNVtB-vWleslXDfEToYR-vk8gFDXc1Eudgd1CStC9H7abmWQqes2sKSUDxgiQB9Bg-mLUbpNSHenhcZ1TT2WesKyptFJa0tjuoBWajrwzW-fsW9np18_fQ6HuQ2hSTPRhYk2RcQL7jSPC8ulK5MkNTwzZaatcEKZSFlEHppogfiokEXipo4iiFxbEz9neyi1e8mA6nhFis5yptG6aKmcK1Jj0WcVkSoND1g0_oG5GZqa02yNZb5tx-y3Psetz2nrcxmw99tXrvuOHrcxvyOtyOm047pGD0ULKB31zcqPxTRBhwuNWsAOdjjxlJqdx4eoVygj0Wkq4iyTCl3PRMQcIXOGr48alw9WpM2nhHaFkKkK2JvtY1qZMuNWrl73POiFIky_hUcqEcsEPwF70Wvz9qdzxHtk1wP2YVTd3wT42768-ifu1-w-91NEKHXvgO11zdodsrvme1e1zRGbiPkl0YXwVB6x_ZPT2cUcv51HRPF4_wQ1u0Gz
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BQEX3o9AC0YCIRVFZJ2HYySEyqNq1XbFoUh7C47tSCttN0uSBe3P4Q_wG5lxki0rYG89IEW5ZGJ5nfHMfDvj-QCe2aSQ0hrjx5T_jwolfYQRsR9qYXgh0ekp7cgmxHCYjkby0wb87M_CUFllbxOdoTalpv_IXw3I8wuRxvLt7KtPrFGUXe0pNFq1OLKL7wjZ6jeHH_D7Pud8_-Pp-wO_YxXwdZyIxo-UzgOec6t4mBue2iKKYs0TXSTKCCukDqRBv6jonqP3ztM8sgNL-S2ujA5x3E24hHZcENgTI3GetQgcHygipsgfYKjfZ1ED17Q0DqlMjvsUFPnpih_svMHmdDz-W6T7R5bWOb_9G__bst2E612YzfbafXELNuz0Nlw56QoJ7sCPd6VZsDNEDsz1i2TjmmEozM7KumHz2hbzCZtVJE7ugLWsRAwDfCdFFegNKws2JRzjOIbHGoWaZsEmVOjCurzXa6aYbo_gNAufIgbDKttUZX_AlU1KIoyaGyInYzRS1TDX8vcufL6QBboHWzhr-wAYnV4WcczDRKFNVam0No-1QaQuAllo7kHQ606mu1buxCgyyZZNqJ26ZahuGalblnqwu3xl1vYxWSf8ghQyIxuH42rVHdXA2VG3sGxPDCKEmWjKPdhekUTbpFce76BK4xzpPohFmCSpRMAdiZAjUEjw9V5rs8521tm5ynrwdPmYRqZ6wKkt560MYm8EJ2tkUinCNMLLg_vtRlr-dI5RLnkzD172O-u3CfxrXR6un-4TuHpwenKcHR8Ojx7BNe6IU6hacRu2mmpud-Cy_taM6-qxMxsMvlz0hvsFzKSl7g
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1fb9MwELe2gSZe-P8nsIGRQEgga6kTxzESQoNRMY1VEwJpb8GxHalS15QkBfXj8DX4dNw5SUcF9G0PSFVecrEc93x3v9z5foQ8cUmhlLOWCcz_x4VWDGCEYJGRlhcKnJ42nmxCjkbp6ak62SA_-7MwWFbZ20RvqG1p8Bv53gA9v5SpUHtFVxZxcjB8PfvKkEEKM609nUarIkdu8R3gW_3q8AD-66ecD999evuedQwDzIhENizWJg95zp3mUW556oo4FoYnpki0lU4qEyoLPlLjNQdPnqd57AYOc11cWxPBuJvkkowFx779x-HH8wxG6LlBAT3FbABhf59RDX0DUxFhyRxnGCCxdMUndp5hczoe_y3q_SNj6x3h8Nr_vITXydUu_Kb77X65QTbc9CbZPu4KDG6RH29Ku6BngCio7yNJxzWFEJmelXVD57WDN6KzCsXRTdCWrYhC4O-lsDK9oWVBp4hvPPfw2IBQ0yzoBAtgaJcPe0k1Ne3RnGbBMJKwtHJNVfYHX-mkRCKpuUXSMoojVQ31rYBvk88XskB3yBbM2t0jFE81SyF4lGiwtTpVzuXCWEDwMlSF4QEJez3KTNfiHZlGJtmyObVXvQxUL0PVy9KAPF8-Mmv7m6wTfobKmaHtg3GN7o5wwOywi1i2LwcxwE8w8QHZWZEEm2VWbu-CesMc8ToQMkqSVAEQj2XEAUAk8HivwVlnU-vsXH0D8nh5G0fGOsGpK-etDGByAC1rZFIlozSGX0Dutptq-eocol_0cgF50e-y3ybwr3W5v366j8g27LPsw-Ho6AG5wj2fChYx7pCtppq7XXLZfGvGdfXQWxBKvlz0fvsFpNmutw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Body+mass+index+is+the+most+useful+predictive+factor+for+the+onset+of+nonalcoholic+fatty+liver+disease%3A+a+community-based+retrospective+longitudinal+cohort+study&rft.jtitle=Journal+of+gastroenterology&rft.au=Miyake%2C+Teruki&rft.au=Kumagi%2C+Teru&rft.au=Hirooka%2C+Masashi&rft.au=Furukawa%2C+Shinya&rft.date=2013-03-01&rft.issn=0944-1174&rft.eissn=1435-5922&rft.volume=48&rft.issue=3&rft.spage=413&rft.epage=422&rft_id=info:doi/10.1007%2Fs00535-012-0650-8&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0944-1174&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0944-1174&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0944-1174&client=summon